Michelson Diagnostics Secures CPT codes for Optical Coherence Tomography imaging of skin 12th July 2017/in Pressemitteilungen, VivoSight /by martinRead more →
VivoSight Dx and Dynamic OCT cleared by the FDA for sale in the US 11th August 2016/in Pressemitteilungen, VivoSight /by martinRead more →
VivoSight OCT used to visualize vascular networks in melanoma and non-melanoma skin cancers 2nd May 2016/in Pressemitteilungen, VivoSight /by nicolaRead more →
Michelson Diagnostics Founder Assumes Leadership Role 11th April 2016/in Firma, Pressemitteilungen /by martinRead more →
Study shows VivoSight OCT is able to differentiate between AK and BCC by quantification of signal intensity and layer thickness 17th March 2016/in Pressemitteilungen, VivoSight /by martinRead more →
Michelson Diagnostics’ Dynamic OCT Imaging Technology reveals changes in Skin Blood Vessels in Real-Time 26th February 2016/in Pressemitteilungen, VivoSight /by martinRead more →
VivoSight Significantly Improves Early-Stage Diagnosis of Basal Cell Carcinoma and Reduces Need for Skin Biopsies 20th October 2015/in Pressemitteilungen, VivoSight /by martinRead more →
VivoSight at EADV Congress 2015 8th October 2015/in Pressemitteilungen, VivoSight /by martinRead more →
Transformative clinical results with VivoSight in the diagnosis of Basal Cell Carcinoma 12th June 2015/in Pressemitteilungen, VivoSight /by rupertRead more →
Michelson Diagnostics launches next generation OCT System – VivoSight Dx 30th April 2015/in Pressemitteilungen, VivoSight /by rupertRead more →